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Abstract
RNA interference (RNAi) elicited by long double-stranded (ds) or
base-paired viral RNA constitutes the major mechanism of antiviral
defence in plants and invertebrates. In contrast, it is controversial
whether it acts in chordates. Rather, in vertebrates, viral RNAs
induce a distinct defence system known as the interferon (IFN)
response. Here, we tested the possibility that the IFN response
masks or inhibits antiviral RNAi in mammalian cells. Consistent
with that notion, we find that sequence-specific gene silencing can
be triggered by long dsRNAs in differentiated mouse cells rendered
deficient in components of the IFN pathway. This unveiled response
is dependent on the canonical RNAi machinery and is lost upon
treatment of IFN-responsive cells with type I IFN. Notably, transfec-
tion with long dsRNA specifically vaccinates IFN-deficient cells
against infection with viruses bearing a homologous sequence.
Thus, our data reveal that RNAi constitutes an ancient antiviral
strategy conserved from plants to mammals that precedes but has
not been superseded by vertebrate evolution of the IFN system.
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Introduction
RNA silencing is a mechanism conserved from plants to mammals
that mediates suppression of gene expression through the use of
small RNAs of 21–30 nucleotides (nt) in length (Ghildiyal & Zamore,
2009; Wilson & Doudna, 2013). These small RNAs guide a wide
range of activities such as the regulation of gene expression, estab-
lishment of heterochromatin, control of transposons and defence
against virus infection (Ghildiyal & Zamore, 2009; Wilson &
Doudna, 2013). Most—albeit not all—mechanisms of RNA silencing
operate through a similar set of processes that are triggered by the
presence within cells of double-stranded RNA (dsRNA) or single-
stranded RNA (ssRNA) containing long base-paired regions. This
was initially demonstrated in C. elegans, in which introduction of
long dsRNA induced the selective degradation of mRNAs bearing
complementary sequences (Fire et al, 1998). The process was
termed RNA interference (RNAi) and relies on the processing of a
perfectly base-paired dsRNA by the type III ribonuclease Dicer into a
class of small RNAs termed small interfering RNAs (siRNAs). One
strand of siRNA is loaded onto Argonaute (Ago) family proteins to
form the RNA-induced silencing complex (RISC), which is then
directed to recognise and cleave cellular mRNAs bearing comple-
mentary sequences (Meister & Tuschl, 2004; Ghildiyal & Zamore,
2009; Wilson & Doudna, 2013). By its very nature, RNAi constitutes
a sequence-specific gene silencing mechanism.
Virus infection is often accompanied by generation of dsRNA or
long base-paired RNAs (Jacobs & Langland, 1996; Weber et al,
2006; Son et al, 2015). These can serve as substrates for Dicer to
generate virus-derived siRNAs (viRNAs) (Ding & Voinnet, 2007;
Kemp & Imler, 2009; Swarts et al, 2014; tenOever, 2016) that are
loaded onto RISC and target complementary viral RNA to block
virus replication. Indeed, viRNA-mediated RNAi constitutes the
primary antiviral defence strategy of plants and invertebrates (Ding
& Voinnet, 2007; Kemp & Imler, 2009; Swarts et al, 2014; tenOever,
2016). Consequently, plant and insect viruses have evolved viru-
lence factors called viral suppressors of RNA silencing (VSRs) that
block various steps of the antiviral RNAi mechanism (Haasnoot
et al, 2007; Wu et al, 2010). Experimental appreciation of the effects
of RNAi on virus accumulation therefore requires the use of
VSR-deficient viruses (Deleris et al, 2006; Wang et al, 2006a;
Diaz-Pendon et al, 2007; Maillard et al, 2013).
Whether RNAi also acts as an antiviral mechanism in mammals
is hotly debated (Parameswaran et al, 2010; Cullen et al, 2013; Li
et al, 2013; Maillard et al, 2013; Backes et al, 2014; Ding & Voinnet,
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2014; Kennedy et al, 2015). Infection of mammalian somatic cells
with various viruses results in little accumulation of viRNA
(Parameswaran et al, 2010; Girardi et al, 2013; Backes et al, 2014;
Bogerd et al, 2014) and, where tested, virus replication is only
modestly affected in Dicer-defective cells (Wang et al, 2006b;
Matskevich & Moelling, 2007; Bogerd et al, 2014). Instead, infection
of vertebrate cells with viruses triggers the innate interferon (IFN)
response, a vertebrate-restricted system of antiviral defence that can
be elicited by the same ds and base-paired RNAs that serve as Dicer
substrates. In the IFN response, those RNAs are generally detected
by members of the RIG-I family of pattern recognition receptors,
which then bind to the mitochondrial adaptor MAVS to initiate a
signalling cascade that culminates in the production and secretion
of IFN-b and IFN-a, among others (Goubau et al, 2013). IFN-a and
IFN-b bind to the IFN receptor (IFNAR), which signals to induce
hundreds of interferon-stimulated genes (ISGs) that work to increase
antiviral resistance (Samuel, 2001; Goubau et al, 2013; Schneider
et al, 2014). For example, the ISG protein kinase R (PKR), when
activated by viral dsRNA, phosphorylates the alpha subunit of the
protein synthesis initiation factor-2, causing inhibition of both viral
and cellular translation (Pindel & Sadler, 2011). Another ISG, the
enzyme 20,50-oligoadenylate synthetase (20-50 OAS), is similarly acti-
vated by viral dsRNA to produce oligo-adenylates that, in turn,
induce activation of another ISG, RNase L, which non-specifically
degrades RNA of viral or cellular origins (Chakrabarti et al, 2011).
Thus, introduction of viral RNA or its mimics in mammalian cells
does not results in sequence-specific gene silencing, but rather in a
global sequence-unspecific reduction in protein expression and
often culminates in cell death (Yang et al, 2001; Paddison et al,
2002). As such, a consensus has emerged that long dsRNA-mediated
RNAi (dsRNAi) and viral dsRNA-mediated RNAi (antiviral RNAi)
have been lost during the course of vertebrate evolution to be
replaced by the IFN system of antiviral defence (Cullen et al, 2013;
tenOever, 2016).
Despite the above observations, long dsRNA has been shown to
induce RNAi in some undifferentiated mammalian cell types, such
as mouse embryonic stem cells (mESCs), mouse embryonic terato-
carcinoma cell lines and in oocytes (Svoboda et al, 2000; Wianny &
Zernicka-Goetz, 2000; Billy et al, 2001; Yang et al, 2001; Paddison
et al, 2002). For example, viral infection of mESCs resulted in RISC
loading with viRNAs that could provide antiviral activity towards a
VSR-deficient homologous virus (Maillard et al, 2013). Interestingly,
oocytes express an alternative isoform of Dicer that lacks the
N-terminal helicase domain (Flemr et al, 2013) and has enhanced
ability to process long dsRNA. Overexpression of the N-terminal
truncated form of human Dicer in 293T cells lacking endogenous
Dicer and PKR conferred the ability to produce functional amounts
of siRNAs and, to some extent, viRNAs (Kennedy et al, 2015). These
observations could indicate that failure to express an appropriate
Dicer isoform underlies the inability of differentiated cells to carry
out dsRNAi and antiviral RNAi. A distinct but not mutually exclu-
sive possibility is that the presence of the IFN response, which is
attenuated in undifferentiated and germ cells (Wood & Hovanessian,
1979; Stein et al, 2005; Wang et al, 2013), may mask or inhibit
dsRNAi and antiviral RNAi in differentiated mammalian cells. Here,
we provide evidence for the latter notion by showing that inactiva-
tion of the IFN pathway in mammalian somatic cells unveils the
presence of long dsRNA-mediated RNAi. Our data suggest that long
dsRNAi and antiviral RNAi could constitute a backup strategy of
antiviral defence that has been preserved during the evolution of
vertebrate immunity.
Results
The hallmark of RNAi is specific silencing of a target RNA upon
introduction of long dsRNA bearing a complementary sequence
(Meister & Tuschl, 2004; Ghildiyal & Zamore, 2009; Wilson &
Doudna, 2013). As mentioned previously, failure to document this
process in the context of viral infection is complicated by the possi-
bility that the virus encodes VSRs (Haasnoot et al, 2007; Wu et al,
2010). Therefore, we designed a virus-free assay to measure long
dsRNA-mediated gene silencing at the single-cell level and tested it
initially in mouse embryonic stem cells (mESCs), in which the pres-
ence of dsRNAi and antiviral RNAi has been reported (Billy et al,
2001; Yang et al, 2001; Paddison et al, 2002; Maillard et al, 2013).
mESCs stably expressing a GFP reporter gene were transfected with
in vitro synthesised Cy5-labelled long dsRNA corresponding to the
first 200 nt of either the GFP (dsRNA-GFP) or, as a control, the
Renilla luciferase (dsRNA-RL) coding sequences; GFP expression in
live single Cy5-positive (transfected) cells was then measured by
flow cytometry (Fig 1A and B). Notably, introduction of dsRNA-GFP
but not dsRNA-RL led to a reduction in GFP expression at 2 days
post-transfection (Fig 1C). To increase temporal resolution, we
switched to mESCs expressing a destabilised form of GFP (d2GFP),
which has a reduced half-life (Li et al, 1998). At 6 h post-
transfection (h.p.t.), d2GFP expression was decreased by either of
the dsRNAs, reflecting sequence-unspecific effects (Fig 1D).
However, at later time points (24–48 h.p.t.), a reduction in d2GFP
signal was maintained and accentuated in mESCs transfected with
dsRNA-GFP but not in cells treated with dsRNA-RL, revealing
sequence-specific gene silencing (Fig 1D). In contrast, transfection
of the same long dsRNAs into a mouse fibroblast cell line (L929)
stably expressing d2GFP resulted in a sequence-unspecific decrease
in GFP signal at all time points examined (Fig 1E). We also noticed
that transfection of long dsRNA induced some cytotoxicity in mESCs
and L929 cells (Appendix Fig S1A and B). This is consistent with
the notion that introduction of long dsRNA mimics virus infection
and causes IFN-dependent cellular shutdown/death, even in mESCs
that have functional PKR despite an attenuated IFN pathway
(Wang et al, 2013).
To address whether the IFN response in differentiated cells was
connected to the failure to reveal sequence-specific gene silencing,
we generated immortalised GFP-expressing Mavs/ mouse embry-
onic fibroblasts (MEFs) (Appendix Fig S2A). Mavs/ MEFs did not
mount an IFN response to dsRNA, unlike their MAVS-sufficient
(Mavs+/) counterparts, which reacted to dsRNA but not siRNA
with upregulation of ISGs and decreased viability (Appendix Fig S2B
and C). GFP expression in viable control Mavs+/ MEFs was unal-
tered by treatment with either dsRNA-RL or dsRNA-GFP, indicating
the lack of gene silencing induced by long dsRNA, but could be
reduced by treatment with siRNAs targeting GFP confirming the
presence of a functional RISC (Fig 2A). In contrast, in Mavs/
MEFs, GFP levels were specifically reduced by dsRNA-GFP, as well
as siRNA targeting GFP, but not by dsRNA-RL (Fig 2A). Importantly,
silencing induced by dsRNA-GFP was not restricted to a subset of
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putatively undifferentiated Mavs/ MEFs as the entire transfected
population shifted towards lower levels of expression (Fig 2A). The
sequence-specific knock-down of GFP was also apparent at the
mRNA level in Mavs/ MEFs and, to a lesser extent, in Mavs+/
heterozygous MEFs (Appendix Fig S2D).
We repeated the experiments in Mavs+/ and Mavs/ MEFs
expressing d2GFP to obtain temporal resolution of dsRNA-induced
gene silencing. At 6 h.p.t., d2GFP levels were reduced by both
dsRNA-RL and dsRNA-GFP in MEFs irrespective of genotype
(Fig 2B). The sequence specificity of the response only became
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Figure 1. Flow cytometry-based assay to monitor gene silencing by long dsRNA.
A Unlabelled or Cy5-labelled dsRNA corresponding to the first 200 nucleotides of either the Renilla luciferase (dsRNA-RL) or the GFP (dsRNA-GFP) coding sequences
visualised on gel stained with ethidium bromide (EtBr-stained, top) or by in-gel fluorescence (bottom).
B Gating strategy used in the flow cytometry-based assay. First, cells were selected (side scatter (SSC) vs. forward scatter (FSC)) and gated for singlets (SSC-Width (W)
vs. FSC) to hence exclude doublets or cell aggregates. The single-cell gate was then further analysed for DAPI, gating on the live cells (DAPI negative). DsRNA-
transfected cells (Cy5 positive) were then gated, and the level of GFP expression was analysed within that population. Flow cytometry counting beads (gated on SSC
vs. FSC plot) were added to quantify cell number in each sample.
C mESCs stably expressing GFP (mESCs-GFP) were mock transfected or transfected with the indicated Cy5-labelled dsRNA, and the level of GFP in Cy5+ cells was analysed
3 days later and is represented as histograms (left). Right panel, bar graphs displaying the percentage of GFP median fluorescence intensity relative to mock control.
D mESCs stably expressing d2GFP (mESCs-d2GFP) were mock transfected or transfected with the indicated Cy5-labelled dsRNA. The level of d2GFP was analysed at the
indicated time points post-transfection and displayed as in (C).
E L929 cells stably expressing d2GFP were mock transfected or transfected with the indicated Cy5-labelled dsRNA, and d2GFP level was measured as in (D).
Data information: All histogram plots are representative of two independent experiments. Each histogram and bar represents a sample size of 10,000 cells. Bar graphs
depict the median fluorescence values normalised to those in mock-transfected samples. Mean values and standard deviations (SD) from two independent experiments
are shown (C, D). Statistical analysis was performed using two-way ANOVA with Sidak’s multiple comparisons test as post-test for unpaired t-test (C) or pairwise
comparisons (D). Significant differences with Student’s unpaired t-test or Sidak’s multiple comparisons test are shown (ns, not significant; **P < 0.01; ***P < 0.001).
Source data are available online for this figure.
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apparent in Mavs/ MEFs at 24–48 h.p.t. with dsRNA-GFP
(Fig 2B). Sequence-specific dsRNA-dependent gene silencing was
also observed in MEFs derived from type I IFN receptor-deficient
mice (Ifnar1/ MEFs) that are competent for type I IFN production
but defective in ISG induction (Fig 2C). Similarly, we could unveil
sequence-specific dsRNA-dependent gene silencing in Mavs+/ MEFs
by blocking IFNAR with a neutralising antibody (Fig 3A). In
contrast, blocking IFNAR in Mavs/ MEFs did not impact the
sequence-specific response, consistent with the fact that they do not
produce IFN in response to dsRNA (Fig 3A). The converse experi-
ment, stimulation of IFNAR in Mavs/ MEFs by addition of recom-
binant IFN, caused a sequence-unspecific decrease in d2GFP
expression in response to either dsRNA-GFP or dsRNA-RL (Fig 3B),
while allowing sequence-specific knock-down of d2GFP by siRNAs
(Appendix Fig S3). In summary, the IFN response to dsRNA in dif-
ferentiated mammalian cells induces ISGs that mask or suppress
sequence-specific responses to long dsRNA.
We next addressed whether the unveiled sequence-specific gene
silencing mediated by long dsRNA in cells deficient in the IFN
response is mediated by the canonical RNAi pathway. A hallmark of
RNAi is the production of 21–25-nt siRNAs following processing by
Dicer of long dsRNA. We therefore transfected Ifnar1/ MEFs with
dsRNA-RL or dsRNA-GFP and analysed total RNA by Northern blot
one day later using appropriate probes. In both sets of transfected
cells, we detected sequence-specific RNAs of ~22 nt in length, in
line with the size of siRNAs typically generated by mammalian Dicer
(Zhang et al, 2002; Vermeulen et al, 2005; Flemr et al, 2013;
Maillard et al, 2013; Kennedy et al, 2015) and similar to the size
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Figure 2. Sequence-specific gene silencing by long dsRNA in cells deficient in the IFN response.
A Mavs+/ and Mavs/ MEFs stably expressing GFP were transfected or not (mock) with the indicated Cy5-labelled dsRNAs (top panels) or siRNAs (bottom panels). GFP
level was measured in Cy5+ cells by flow cytometry 72 h (hours) post-transfection.
B Mavs+/ and Mavs/ MEFs stably expressing d2GFP were transfected or not (mock) with the indicated Cy5-labelled dsRNAs. The level of d2GFP in Cy5+ cells was
measured at various time points post-transfection as indicated. Histogram plots show d2GFP level 48 h post-transfection. Bar graphs show three time points as
indicated.
C WT, Ifnar1+/ or Ifnar1/ MEFs stably expressing d2GFP were transfected or not (mock) with the indicated Cy5-labelled dsRNAs, and d2GFP level in Cy5+ cells was
monitored by flow cytometry at 48 h post-transfection.
Data information: All histogram plots are representative of 10 (A, B) or 4 (C) independent experiments. Each histogram and bar represents a sample size of 10,000 cells.
Bar graphs depict the median fluorescence values normalised to those in mock-transfected samples. Mean values and SD of three independent experiments are shown
(B, C). Statistical analysis was performed using two-way ANOVA with Sidak’s multiple comparisons test as post-test for pairwise comparisons. Significant differences with
Sidak’s multiple comparisons test are shown (ns, not significant; **P < 0.01; ***P < 0.001).
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generated by incubating dsRNA-RL or dsRNA-GFP with human Dicer
complexes in vitro (Fig 4A). We then directly addressed the role of
Dicer in dsRNA-transfected cells. To obviate the detrimental effect
of complete Dicer ablation, which would prevent miRNA generation
and lead to strong selection for atypical clones (Kim et al, 2009), we
chose to decrease its expression in Mavs/ MEFs expressing d2GFP
by using shRNA-mediated silencing (Fig 4B). The sequence-specific
silencing of d2GFP by dsRNA-GFP was highly reduced following
knock-down of Dicer (DICER shRNA #1) but was unaffected by
either a non-targeting shRNA control or an inefficient shRNA against
Dicer (DICER shRNA #2) (Fig 4C). Next, we evaluated the role of
RISC. Of the four mammalian Ago proteins (Ago1–4), only Ago2 is
essential for experimental RNAi induced by siRNA (Meister &
Tuschl, 2004; Wilson & Doudna, 2013). We therefore used CRISPR
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Figure 3. The IFN pathway negatively influences the detection of the sequence-specific gene silencing.
A Mavs+/ and Mavs/ MEFs stably expressing GFP were incubated with either a neutralising antibody against IFNAR (a-IFNAR Ab), an isotype control antibody (IgG1)
or no antibody (no Ab). Cells were then transfected or not (mock) with Cy5-labelled dsRNA as indicated and GFP level monitored in Cy5+ cells 72 h post-transfection.
B Mavs/ MEFs stably expressing d2GFP were treated with recombinant IFN (200 U ml1) for 24 h prior to transfection or not (mock) with Cy5-labelled dsRNA, as
indicated. IFN treatment was maintained for 2 days post-transfection and then the GFP level was monitored in Cy5+ cells.
Data information: All histogram plots are representative of two (A) or three (B) independent experiments. Each histogram and bar represents a sample size of 10,000
cells. Bar graphs depict median fluorescence values normalised to those in mock-transfected samples. Mean values and SD of three independent experiments are shown
(B). Statistical analysis was performed using two-way ANOVA with Sidak’s multiple comparisons test as post-test for pairwise comparisons. Significant differences with
Sidak’s multiple comparisons test are shown (ns, not significant; ***P < 0.001).
Figure 4. Sequence-specific gene silencing by long dsRNA depends on Dicer and Ago2.
A Northern blot analysis of Ifnar1/ MEFs at 24 h.p.t. with the indicated dsRNA or transfection reagent alone (mock) using a probe specific for dsRNA-GFP (top) or
dsRNA-RL (bottom). Reactions from a dicing assay using the indicated dsRNA incubated in vitro with immunoprecipitated FLAG-human Dicer were loaded in parallel.
Two lanes (delimited by dashed lines) were left empty between the Ifnar1/ MEFs transfected samples and the in vitro dicing assay reactions. A miRNA marker
containing three synthetic ssRNA oligonucleotides of 17, 21 and 25 nt in length was run in parallel. Endogenous U6 was used as a loading control. Signals
corresponding to the dsRNA-derived siRNAs are indicated with an arrow. The membrane was first probed for dsRNA-GFP (top), then probed for the miRNA marker
(top left) and subsequently stripped and reprobed for dsRNA-RL (middle) and finally stripped and reprobed for both U6 (bottom) and for the miRNA marker again
(middle left).
B Western blot of Dicer in d2GFP-expressing Mavs/ MEFs either not transduced (NT) or transduced to express a non-targeting shRNA control (CTL shRNA) or two
different Dicer-specific targeting shRNAs (DICER shRNA #1 and #2). P97 served as a loading control.
C Cells described in (B) were transfected or not (mock) with the indicated Cy5-labelled dsRNAs, and d2GFP level in Cy5+ cells was monitored by flow cytometry 48 h
later. Please note that the biphasic pattern of d2GFP level observed in dsRNA-GFP transfected cells is caused by a lower transfection efficiency of dsRNA in these cells
giving rise to significant amounts of lowly transfected cells that do not display a decreased level of d2GFP.
D Western blots of Ago2 in parental Mavs/ MEFs stably expressing d2GFP and three Mavs/ Ago2/ clones generated by CRISPR/CAS9-mediated genome
engineering. P97 served as a loading control.
E Mavs/ (parental line) and Mavs/ Ago2/ MEFs (clone 5.1) stably expressing d2GFP were transfected or not (mock) with the indicated Cy5-labelled dsRNAs and
d2GFP level in Cy5+ cells was monitored by flow cytometry 48 h later.
Data information: Histogram plots are representative of two independent experiments (C) or of two independent CRISPR clones (E). Each histogram and bar represents a
sample size of 10,000 cells. Bar graphs depict median fluorescence values normalised to those in mock-transfected samples. Mean values and SD of two independent
experiments (C) or of two independent CRISPR clones (B) are shown. Statistical analysis was performed using two-way ANOVA with Sidak’s multiple comparisons test as
post-test for pairwise comparisons. Significant differences with Sidak’s multiple comparisons test are shown (ns, not significant; *P < 0.05; ***P < 0.001).
Source data are available online for this figure.
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technology to delete Ago2 in Mavs/ MEFs expressing d2GFP
(Fig 4D). The early sequence-unspecific decrease in d2GFP levels
induced by either dsRNA-RL or dsRNA-GFP was not affected by loss
of Ago2 in CRISPR-targeted clones (Fig 4E). In contrast, the
sequence-specific silencing of d2GFP observed 48 h.p.t. of dsRNA-
GFP in Mavs/ MEFs was completely abolished in Mavs/
Ago2/ MEFs (Fig 4E). We independently generated different
Mavs/ Ago2/ MEFs clones expressing stable GFP rather than
d2GFP and confirmed the essential role of Ago2 in the sequence-
specific response to long dsRNAs, as well as to siRNAs
(Appendix Fig S4A–C). We further generated Ago1/-CRISPR-
targeted clones and showed that, in contrast to Ago2, Ago1 is
dispensable for dsRNA-dependent sequence-specific gene silencing
(Appendix Fig S4D–F).
Ago2 is the only member of the Ago family capable of catalysing
endonucleolytic cleavage (“slicing”) of target transcripts, an activity
that has been conserved in vertebrates (Tolia & Joshua-Tor, 2007).
To assess the importance of the “slicing” activity of Ago2 in the
sequence-specific response to long dsRNA, we complemented
Ago2/ Mavs/ clones with a wild-type (WT) or a catalytic
mutant (D597A) version of mouse Ago2 (mAgo2; Fig 5A). As previ-
ously reported (Liu et al, 2004; Meister et al, 2004), WT mAgo2 but
not mutant mAgo2 D597A supported silencing of GFP induced by
siRNA (Appendix Fig S5). Similarly, only the WT but not the cata-
lytic mutant version of mAgo2 was able to restore sequence-specific
GFP silencing in Ago2/ Mavs/ clones transfected with dsRNA-
GFP (Fig 5B). We conclude that the sequence-specific response to
long dsRNA in IFN-deficient cells critically depends on the catalytic
activity of Ago2, as well as on Dicer, and, therefore, fulfils the crite-
ria of long dsRNA-mediated RNAi (dsRNAi).
We then addressed whether dsRNAi can be used as a mechanism
for antiviral defence in mammalian cells independently of the IFN
system. We transfected Ifnar1/ MEFs with either dsRNA-RL or
dsRNA-GFP and infected them one day later with a recombinant
fully replicative Semliki Forest virus (SFV), a positive-sense (+)
ssRNA virus, bearing a Renilla luciferase coding sequence
(SFV-Rluc). Notably, transfection with dsRNA-RL but not dsRNA-
GFP protected the cells from SFV-Rluc, leading to a 40- to 70-fold
decrease in virus replication, whether measured at the level of
Renilla luciferase activity or by plaque assay (Fig 6A–C,
Appendix Fig S6A). Antiviral activity conferred by dsRNA-RL but
not dsRNA-GFP was similarly observed in Mavs/ MEFs infected
with SFV-RLuc (Fig 6C, Appendix Fig S6A). To formally establish
that viral restriction was due to dsRNAi, we compared Ago2/
A
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Figure 5. The endonucleolytic activity of Ago2 is essential for sequence-
specific gene silencing by long dsRNA.
A Western blots for Ago2 (top) and HA tag (bottom) of parental Mavs/
MEFs and two Mavs/ Ago2/ clones (clone 5.2 and 5.3; see Fig 4A) stably
expressing d2GFP and transduced with an empty vector or a vector
encoding HA-tagged wild-type (HA-mAgo2 WT) or catalytic mutant (HA-
mAgo2 D597A) versions of mouse Ago2. b-actin served as a loading control.
The membrane was first analysed for Ago2 and b-actin, stripped and then
analysed for the HA tag.
B Parental non-transduced (NT) Mavs/ MEFs and complemented Mavs/
Ago2/ MEFs as described in (A) were transfected or not (mock) with the
indicated Cy5-labelled dsRNAs, and d2GFP level in Cy5+ cells was monitored
by flow cytometry 48 h later.
Data information: All histogram plots are representative of two independent
experiments and a sample size of 10,000 cells. Bar graphs depict median
fluorescence values normalised to those in mock-transfected samples. Mean
values and SD of two independent CRISPR clones transduced with an empty
vector or a vector encoding HA-mAgo2 WT or HA-mAgo2 D597A (B) are shown.
Statistical analysis was performed using two-way ANOVA with Sidak’s
multiple comparisons test as post-test for pairwise comparisons. Significant
differences with Sidak’s multiple comparisons test are shown (ns, not
significant; **P < 0.01; ***P < 0.001).
Source data are available online for this figure.
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Mavs/ MEFs complemented with wild-type or catalytic mutant
HA-mAgo2. Transfection of dsRNA-RL conferred antiviral activity
against incoming SFV-Rluc in independent Ago2/ Mavs/ MEF
clones complemented with wild-type HA-mAgo2 but not in cells
transduced with an empty vector or in cells stably expressing the
mutant HA-mAgo2 D597A (Fig 6D, Appendix Fig S6B). Thus,
dsRNA can vaccinate IFN-deficient cells to provide sequence-specific
protection from incoming viruses.
Finally, we tested whether the RNAi pathway is sufficient to
restrict virus accumulation in IFN-deficient cells. We first infected
Ago2/ Mavs/ and parental Mavs/ MEFs with reovirus
(Reo) and Sindbis virus (SINV), a dsRNA virus and a (+)ssRNA
virus, respectively. There was wide variation in virus accumula-
tion in different Ago2/ Mavs/ MEFs clones, with no pattern
indicative of a consistent difference from the parental Mavs/
MEFs (Appendix Fig S7A and B). To alleviate the effects of
clonal variation, we focused our comparison on single Ago2/
Mavs/ MEFs clones complemented with wild-type vs. catalytic
mutant HA-mAgo2. We infected these cells with SFV-Rluc
because, as mentioned above, this virus was susceptible to
dsRNAi (Fig 6D, Appendix Fig S6B). However, none of the clones
displayed any differences in intrinsic resistance to infection
(Appendix Fig S7C).
The possible expression of virally encoded VSRs complicates the
interpretation of those experiments. Therefore, we also tested the
role of RNAi in restriction of a mutant influenza A virus (IAV) lack-
ing NS1 (IAV DNS1), a protein previously shown to inhibit the
production of long dsRNA-derived siRNAs in plant (Bucher et al,
2004; Delgadillo et al, 2004; de Vries et al, 2009) and human cells
(Kennedy et al, 2015), as well as prevent antiviral RNAi in Droso-
phila cells (Li et al, 2004). However, the replication of IAV DNS1,
like that of parental wild-type IAV, was similar in Ago2/ Mavs/
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Figure 6. Long dsRNA vaccinates cells against viruses bearing a homologous sequence.
A Ifnar1/ MEFs were transfected with the indicated Cy5-labelled dsRNA and, the next day, they were infected with SFV-Rluc at the indicated multiplicities of
infection (MOI). Renilla luciferase activity was measured 24 h later.
B As in (A) but SFV-Rluc virus titre was measured by plaque assay and expressed as plaque-forming units (PFU) per ml of supernatant at 24 h post-infection (MOI = 0.1).
C As in (A) but with Ifnar1/ or Mavs/ MEFs and a single dose of SFV-Rluc (MOI = 0.1).
D As in (A) but with two Mavs/ Ago2/ clones (clone 5.2 and 5.3) individually complemented to express wild-type (HA-mAgo2 WT) or a catalytic mutant (HA-mAgo2
D597A) version of mAgo2 or transduced with a control vector (as described in Fig 5). SFV-Rluc was used at an MOI = 0.1.
Data information: Each bar represents mean + SD of biological duplicates, and numbers above each pair of bars depict the fold reduction in viral activity achieved with
dsRNA-RL vs. dsRNA-GFP treatment. Data are representative of four (A), two (B, C) and six (D) independent experiments.
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MEFs reconstituted to display an intact or a defective RNAi pathway
(Appendix Fig S7D). Finally, because IAV is a negative-sense ssRNA
virus and may not produce sufficient amounts of dsRNA (Pichlmair
et al, 2006; Weber et al, 2006), we also tested a (+)ssRNA picor-
navirus, EMCV. As a precaution, we chose an EMCV mutant lacking
the L gene, which encodes an IFN antagonist (Hato et al, 2007) that
could potentially act as a VSR. However, again, we did not see a dif-
ference between Ago2/ Mavs/ MEF clones complemented with
HA-mAgo2 vs. mutant HA-mAgo2 D597A in resistance to EMCV DL
(Appendix Fig S7E). Therefore, in our experimental conditions using
immortalised MEFs, antiviral RNAi is only patent after vaccination
with dsRNA.
Discussion
Although dsRNAi has been observed in plants and invertebrates, as
well as in several undifferentiated mammalian cells, it has so far not
been generally documented in differentiated cells (Svoboda et al,
2000; Wianny & Zernicka-Goetz, 2000; Billy et al, 2001; Yang et al,
2001; Paddison et al, 2002). Here, we reveal that dsRNAi can be
unveiled in somatic cells upon ablation of the IFN response.
Notably, dsRNAi is not a rare event restricted to a sub-group of cells
but one that can be observed in all cells within the population and
that achieves knock-down efficiencies comparable to RNAi induced
with siRNA. Finally, activation of this pathway in cells by long
dsRNA confers antiviral resistance to subsequent homologous virus
infections, indicating that mammalian cells can be “vaccinated” by
RNA in a virus-specific manner. Our results establish that somatic
cells are fully equipped to mediate functional RNAi from long
dsRNA substrates, yet the effects of this activity are generally
masked or inhibited by those of the IFN pathway.
How the IFN response prevents experimental observation of
dsRNAi is at present unclear. It is conceivable that some ISGs
actively suppress dsRNAi. This is likely to occur at the level of
Dicer as, in our hands, IFN treatment or the presence or absence
of the IFN pathway did not affect siRNA-mediated interference. In
contrast, a recent study with human cells reported that activation
of the IFN pathway through MAVS led to inhibition of RISC-mediated
cleavage and repression activities (Seo et al, 2013). Alternatively,
the sequence-specific hallmark of dsRNAi might be masked by
sequence-unspecific effects resulting from the activity of ISGs, which
cause a dsRNA-dependent shutdown in cellular protein synthesis
and/or induce cell death (Samuel, 2001; Schneider et al, 2014). Irre-
spective of mechanism, our data suggest that RNAi might be espe-
cially important in conditions of limited IFN induction or in cellular
niches that possess a reduced IFN response pathway.
In our study, the RNAi pathway was effectively triggered by
introduction of long dsRNA and provided sequence-specific resis-
tance to virus infection. Yet, in our experimental system, this resis-
tance was not detected without prior introduction of long dsRNA
into the cells. The failure to observe RNAi after virus infection of
IFN-deficient cells suggests several non-mutually exclusive possibili-
ties. Many viruses, including vertebrate ones, encode putative VSRs
that might obscure RNAi effects on virus accumulation (Ding &
Voinnet, 2007; Haasnoot et al, 2007; Wu et al, 2010). We did not
detect an effect of RNAi on resistance to IAV DNS1 or EMCV DL, yet
the role of other putative VSRs warrants further investigation.
Additionally, dsRNAs derived from some viruses (e.g. SFV replica-
tion intermediates) might be poor substrates for Dicer due to intrin-
sic features (e.g. 50 cap modifications) or due to the fact that they
are sequestered inside membrane-bound replication complexes
(“viral factories”) (Miller & Krijnse-Locker, 2008; den Boon &
Ahlquist, 2010). Alternatively, the amplitude and/or kinetics of the
dsRNAi response upon virus infection and/or the amount of dsRNA
substrate produced by viral replication might not be sufficient to
provide effective antiviral protection in the cell types that we stud-
ied. In this regard, a possibility to explore is that the magnitude of
RNAi is greater in specific cell types, perhaps negatively correlating
with IFN responsiveness as discussed above. Interestingly, whereas
IFN acts primarily to confer broad-spectrum resistance to viral infec-
tion, the RNAi pathway could provide infected cells with an innate
mechanism of immune memory and specificity as suggested by our
cellular vaccination experiments. Our demonstration of the coexis-
tence of dsRNAi and the IFN response in mammals opens the door
to future studies designed to establish the relative contribution of
these two forms of antiviral defence to vertebrate protection from
viral infection.
Materials and Methods
Cells
All cells were mycoplasma negative. E14 mouse embryonic stem
cells (mESCs), L929, Vero, BHK-21 cells were obtained from Cancer
Research UK Cell Services. HEK 293T cells were a kind gift from
Didier Trono (EPFL, Lausanne, Switzerland). L929, Vero and HEK
293T cell lines were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco, Life Technologies) supplemented with 10% foetal
calf serum (FCS) (Autogen Bioclear UK, Ltd), 2 mM glutamine,
100 U ml1 penicillin, 100 U ml1 streptomycin and were grown at
37°C in 10% CO2. BHK-21 were cultured in Glasgow minimum
essential medium (GMEM) (Sigma) containing 10% FCS, 0.2% tryp-
tose phosphate broth (TBP) and 100 U ml1 penicillin, 100 U ml1
streptomycin an grown at 37°C in 10% CO2. E14 mESCs were
cultured in GMEM (Sigma), containing 15% embryonic stem cell-
qualified FCS (Gibco, Life Technologies), 1,000 U ml1 ESGRO
leukaemia inhibitory factor (Millipore), 0.1 mM b-mercaptoethanol
(Gibco, Life Technologies), 100 U ml1 penicillin, 100 U ml1 strep-
tomycin, 2 mM glutamine, 1 mM sodium pyruvate (Gibco, Life Tech-
nologies) and non-essential amino acids (Gibco, Life Technologies)
on a gelatin-coated support in the absence of feeder cells. The culture
medium was changed daily. mESCs were grown at 37°C in 8% CO2.
MEFs were prepared from 13.5-day Mavs/ or Ifnar/ mouse
embryos using standard protocols. They were cultured in DMEM
(Gibco, Life Technologies) supplemented to contain 10% FCS (Auto-
gen Bioclear UK, Ltd), 100 U ml1 penicillin, 100 U ml1 strepto-
mycin and 2 mM glutamine. Primary MEFs were then immortalised
with simian virus 40 large T antigen as described (Schulz et al, 2010).
Plasmids
MLV-based retroviral vectors were produced using packaging
constructs containing Moloney MLV (pCIGPB) gag-pol ORF. Lenti-
virus-based vectors were produced with the packaging construct
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pR8.71 and the vector pRRLsin PGK GFP or pRRLsin PGK d2GFP.
The env construct for all viral productions was pMD2.G encoding
vesicular stomatitis virus G protein. pCIGPB, pR8.71, pRRLsin PGK
GFP and pMD2.G were kindly provided by D. Trono. The amino
acid coding sequence of mouse Ago2 with a N-terminal epitope
derived from influenza virus hemagglutinin (HA) was inserted in
pLHCX MLV vector (Clontech) allowing for hygromycin selection of
transduced cells. Site-directed mutagenesis of pLHCX-HA-mAGO2 to
generate the catalytic mutant version of HA-mAGO2 was performed
with the XL QuickChange mutagenesis kit (Stratagene). Specificity
of mutagenesis was checked by sequencing. Recombinant SFV-Rluc
was generated using the infectious DNA clone pCMV-SFV(3H)Rluc
as previously described (Tamberg et al, 2007). pCAGGS-Flag-
hsDicer was a gift from Phil Sharp (Addgene plasmid # 41584)
(Gurtan et al, 2012). All primers used to generate pLHCX-HA-mAgo2
WT and pLHCX-HA-mAgo2 D597A are listed in Appendix Table S1.
Virus infections
Sindbis virus and reovirus strain type 3 Dearing (T3D) were a gift
from Ian Kerr and Terence Dermody, respectively. Influenza A/PR/
8/34 DNS1 was a gift from T. Muster (University of Vienna,
Austria). EMCV DL mutant was generated from the infectious DNA
clone pEC9 EMCV DL plasmid (kind gift from Ann C Palmenberg) as
described (Deddouche et al, 2014). Appropriate doses of virus
diluted in 100 ll DMEM without serum were added on cells in a
24-well plate and left for 2 h at 37°C. The medium was then replaced
with 500 ll of DMEM supplemented with 10% FCS, 2 mM gluta-
mine, 100 U ml1 penicillin, 100 U ml1 streptomycin, and cells
were then incubated at 37°C. For measurements of viral load by
qRT–PCR, cells were washed with PBS, trypsinised and collected by
centrifugation. After a subsequent wash with PBS, cells were lysed
and RNA extracted using RNeasy Mini Kit (Qiagen). For measure-
ments of infectious particles accumulation, cell supernatants were
collected, clarified by centrifugation at 1,000 g for 15 min, aliquoted
and frozen at 80°C for subsequent analysis by plaque assay.
Preparation of long dsRNA
PCR fragments corresponding to the first 200 nt of the GFP coding
sequence were amplified from pRRL-PGK-GFP using primers addi-
tionally containing a T7 promoter sequence, with one PCR fragment
allowing the production of (+)-sense RNA GFP and the other used to
generate the ()-sense RNA. Similarly, two PCR fragments corre-
sponding to the first 200 nt of Renilla luciferase were amplified from
pRL-TK plasmid (promega). Primers used to generate the PCR prod-
ucts are listed in Appendix Table S1. The PCR fragments were puri-
fied using QIAquick PCR purification kit (Qiagen), and in vitro
transcription (IVT) with T7 RNA polymerase (T7 MEGAscript kit,
Ambion) was performed overnight at 37°C. To label the IVT RNA,
1/10th Cy5-CTP (Amersham CyDye Fluorescent Nucleotides Cy5-
CTP, GE Healthcare Life sciences) was included in the IVT reaction.
The next day, IVT RNA was digested with Turbo DNase for 30 min
at 37°C and unincorporated nucleotides were removed by purifying
the IVT RNA on an Illustra MicroSpin G-25 column (GE Healthcare
Life), followed by phenol-chloroform extraction and an additional
purification on a G-25 column. The correct sizes of the IVT RNAs
were verified on a TBE 2% agarose gel. DsRNA was then generated
by mixing an equal volume of (+)-sense IVT RNA and ()-sense IVT
RNA in annealing buffer (5 mM Tris pH 7.5, 25 mM NaCl, 0.5 mM
EDTA), incubation at 65°C for 10 min followed by slow cool down
to RT. To remove single-stranded RNA molecules, the mixture was
treated with RNase I, a single-stranded RNA-specific RNase for
10 min. dsRNA was then purified by phenol-chloroform extraction,
quantified by Nanodrop and separated on a TBE 2% agarose gel to
verify size and integrity. RNA was visualised by ethidium bromide
staining and in-gel fluorescence using IMAGEQUANT LAS 4000
(GE Healthcare).
Viral vector production
All vector production was performed by CaPO4-mediated transient
co-transfection of the retroviral vector, gag-pol and env encoding
constructs. Briefly, subconfluent HEK 293T cells were co-transfected
with 21.5 lg of vector, 14.6 lg packaging constructs and 7.9 lg env
constructs in a 15-cm plate. Cells were washed 16 h post-transfection,
and supernatants were harvested 24 h later. Recombinant retroviral
vectors containing supernatants were centrifuged, filtered and concen-
trated by ultracentrifugation.
Engineering of stable cell lines
To generate GFP or d2GFP-expressing lines, lentiviral vectors encod-
ing GFP or d2GFP were produced using pRRLsin PGK GFP or
pRRLsin PGK d2GFP plasmids as described above. Concentrated
lentiviral particles were added to 5 × 104 target cells. 72 h post-trans-
duction, cells were FACSsorted (on a BD FACSAria or a BDFACSAria
Fusion) for GFP-positive cells and expanded. MLV-based retroviral
vectors encoding wild-type or mutant version of mouse Ago2 were
produced using the pLHCX-derived plasmids, and concentrated retro-
viral vectors were added to 5 × 104 target cells. Two days post-
transduction, cells were expanded and transduced cells were selected
by adding hygromycin B (Sigma) at a concentration of 200 lg ml1.
Dicer knock-down cells
Five MISSION pLK0.1-puro Dicer shRNA (Sigma) and MISSION
pLK0.1-puro non-target shRNA control plasmids (Sigma) were used
together with lentiviral packaging and envelope constructs to
produce individual lentiviral vectors particles as described above.
Mavs/ stably expressing d2GFP were transduced with lentiviral
vectors. Knock-down efficiency was assessed by immunoblot, and
two lines stably expressing shRNA against Dicer and cells express-
ing non-target control shRNA were used for experiments.
Production of recombinant SFV-Rluc
BHK-21 cells at 80% confluency in a single well of a six-well plate
were transfected by Lipofectamine 2000 (Invitrogen) with 1 lg of
infectious DNA plasmid pCMV-SFV(3H)Rluc. The transfection mix
was first incubated for 20 min at RT, cells were washed once with
OptiMEM, and the transfection mixture was then directly added on
the cells. After 3 h of incubation at 37°C, the mixture was removed
and infection medium (GMEM, 0.2% BSA, 20 mM Hepes) was
added. Cells were incubated for 24 h at 37°C until the first signs of a
cytopathology. The supernatant was then harvested and clarified by
The EMBO Journal ª 2016 The Authors
The EMBO Journal dsRNAi in differentiated mammalian cells Pierre V Maillard et al
10
Published online: November 4, 2016 
centrifugation (1,000 g, Eppendorf 5810, swing rotor) for 15 min at
4°C and by filtration (0.4 lm filters) to remove remaining cells and
cell debris. Glycerol was added to a final concentration of 5%, and
viral stocks were aliquoted and stored at 80°C. Stocks were titrated
by plaque assay on BHK-21 cells.
CRISPR-mediated genome engineering
Mavs/ Ago2/ and Mavs/ Ago1/ cells stably expressing
GFP (Appendix Fig S4) or d2GFP (Fig 4) were generated by
CRISPR-Cas9-mediated genome engineering using the CRISPR design
tool provided by the Zhang laboratory (http://www.genome-
engineering.org). A target sequence in the second exon
(GTGGTGCCGAAGTCCGGCCGAGG, sgRNA 1, Fig 4, Appendix Fig
S4) or in the fourth exon (GATCGTCTCGAAGGGGACGCTGG, sgRNA
2, Appendix Fig S4) of murine Ago2 was chosen, and a target
sequence in the second exon (GATTGACGTTTACCATTACGAGG,
Appendix Fig S4) of murine Ago1 was selected. The appropriate
oligonucleotides were cloned into the BbsI site of pSpCas9(BB)-2A-
puro plasmid obtained from the laboratory of Feng Zhang via
Addgene (https://www.addgene.org, plasmid 48139) according to
the cloning protocol provided by the laboratory (http://www.
genome-engineering.org). Following puromycin selection (48 h) and
single-cell cloning, colonies were screened for correct targeting of
Ago2 by measuring the efficiency of siRNA-mediated knock-down of
GFP. Ago2 and Ago1 deficiency was confirmed by immunoblot. All
primers used for CRISPR/Cas9-mediated genome engineering in this
study are listed in Appendix Table S1.
RT–PCR
Total RNA was extracted using RNeasy Mini Kit columns with
DNase treatment according to the manufacturer’s instructions (Qia-
gen). Five hundred ng of RNA was reverse transcribed using
random hexamers (Thermo Scientific) and SuperScript II Reverse
Transcriptase (Thermo Fisher Scientific). cDNA was then diluted
five times in nuclease-free water and analysed for gene expression
by qPCR using TaqMan Gene expression Assays (for GFP and
Gapdh, Applied Biosystems) or SYBR green (Applied Biosystems).
Reactions were carried out using ABI 7500 Fast machines (Applied
Biosystems). Relative expression values were calculated using the
DDCt method. Ct values were normalised to Gapdh or Hprt house-
keeping gene. All primers used for qRT–PCR using SYBR green are
listed in Appendix Table S1.
DsRNA or siRNA transfection and flow cytometry
4 × 104 cells per well were seeded on a 24-well plate. One day later,
200 ng of Cy5-labelled dsRNA-RL or Cy5-dsRNA-GFP or 15 pmol
siRNA-GFP (Silencer GFP siRNA, Ambion) or 15 pmol siRNA
control (Silencer negative control siRNA # 1, Ambion) or transfec-
tion reagent alone (mock) was transfected into cells using Lipofec-
tamine 2000 (Invitrogen). To test the effect of IFN on dsRNA/
siRNA-mediated gene silencing, 200 U of recombinant IFN A/D
(PBL Assay Science) was added at the time of seeding the cells. To
block the IFN receptor, an anti-IFNAR antibody (LEAF purified anti-
mouse IFNAR-1 antibody, Biolegend) was included at 10 lg ml1.
An isotype-matched irrelevant specificity antibody (LEAF purified
mouse IgG1, k isotype control antibody, Biolegend) was used as a
control. For analysis, cells were recovered by trypsinisation, washed
in PBS and resuspended in FACS buffer (PBS, 1% FCS, 5 mM
EDTA) containing the live/dead cell discriminator dye DAPI, as well
as a fixed amount of fluorescent reference beads (Coulter CC Size
standard L10, Beckman Coulter) in order to allow for flow cytome-
try-based cell counting. Flow cytometric analyses were performed
with an LSRFortessa (BD Biosciences) acquiring a sample size of
10,000 cells to meet statistical robustness. Data were analysed using
FlowJo (Tree Star).
Small RNA Northern blot
2 × 106 cells were seeded on a 10-cm dish. One day later, 4.5 lg of
dsRNA-RL or dsRNA-GFP or transfection reagent alone (mock) was
transfected into cells using Lipofectamine 2000 (Invitrogen). 24 h
post-transfection, total RNAs were extracted and purified using
TRIzol Reagent (Invitrogen) according to manufacturer’s instruc-
tions and resuspended in 50% formamide. The yield was deter-
mined using a spectrophotometer and 25 lg of total RNAs as well
as 24 ng of miRNA marker (New England Biolabs) and 2 ll of
in vitro dicing reactions (see section below) were resolved on
denaturing 17.5% polyacrylamide/urea gels, transferred on a
HybondTM-NX membrane (GE Healthcare) and chemically cross-
linked using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)
as previously described (Pall & Hamilton, 2008). Perfect-Hyb buffer
(Sigma) was used for the hybridisation step. DNA oligonucleotides
complementary to U6 or to the miRNA marker (New England
Biolabs) were 50end-labelled with c-32P-ATP (PerkinElmer) using T4
polynucleotide kinase (Thermo Scientific). The probe used to detect
GFP or Renilla luciferase siRNAs was made by random priming in
the presence of a-32P-dCTP (PerkinElmer) using the Prime-a-gene
kit (Promega). The templates used for these random priming reac-
tions were PCR fragments corresponding to the first 200 nt of the
GFP coding sequence and Renilla luciferase, respectively. The PCR
fragments were purified using QIAquick PCR purification kit (Qia-
gen). Membranes were stripped with boiling 0.1% SDS solution
twice. Probes used for Northern blot are listed in
Appendix Table S1.
Purification of recombinant human Dicer and in vitro
dicing assay
pCAGGS-Flag-hsDicer (Addgene plasmid # 41584) (Gurtan et al,
2012) was transfected into 293T cells using Lipofectamine 2000
according to the manufacturer’s instructions. Twenty-eight hours
post-transfection, cells were lysed in lysis buffer (30 mM Tris pH
6.8, 50 mM NaCl, 3 mM MgCl2, 5% glycerol, 0.4% NP-40 and
protease inhibitors (Roche)) and the lysate was cleared by centrifu-
gation. FLAG-Dicer was immunoprecipitated using anti-FLAG M2
beads (Sigma), washed 5 × in lysis buffer and 1 × in lysis buffer
without NP-40. FLAG-Dicer was eluted from the beads using
0.5 mg ml1 3× FLAG Peptide (Sigma) and lysis buffer without
NP-40. The purity and concentration of FLAG-Dicer was analysed
by SDS–PAGE and Coomassie staining, using BSA as a standard.
500 nM FLAG-Dicer was incubated with 50 nM dsRNA in dicing
buffer (30 mm Tris pH 6.8, 50 mM NaCl, 3 mM MgCl2, 5% glycerol,
4 mM DTT, RNAsin) for 1 h at 37°C. Reactions were purified by
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phenol/chloroform extraction, resuspended in 50% formamide and
analysed by small RNA Northern blot.
Protein analysis
Cell lysates were prepared in RIPA buffer (PBS with 1% NP-40,
0.5% sodium deoxycholate and 0.1% SDS) supplemented with
protease inhibitor cocktail (Complete, Roche). Protein content was
quantified using the Pierce BCA Protein Assay Kit, and equal
amounts of protein were resolved on a Tris–glycine SDS–polyacry-
lamide gel and transferred by electroblotting onto Inmobilon-P
PVDF membranes (Millipore) and incubated sequentially with the
relevant primary antibodies and HRP-conjugated secondary anti-
body in PBS with 0.1% Tween-20 and 5% non-fat dried milk. Lumi-
nata Crescendo Western HRP substrate (Millipore) was used for
detection. For re-probing, membrane was stripped using Restore
Western blot Stripping Buffer (Thermo Scientific) according to
manufacturer’s instructions. Stripping efficiency was verified by
treating the stripped membrane with Luminata Crescendo HRP
substrate and confirming the absence of any signal following 1-h
exposure. The following antibodies were used: HA-HRP (clone
3F10, Roche), Ago2 (C34C6, Cell Signaling Technology), Ago1
(D84610, Cell Signaling Technology), Dicer, MAVS (Cell Signaling
Technology), GFP-HRP (D5.1, Cell Signaling Technology), b-actin-
HRP (13E5) and p97 (Fitzgerald Industries).
Plaque assay
BHK-21 or Vero cells were seeded at 4 × 105 cells per well in a 12-
well plate. The next day, 220 ll of 10-fold serial dilutions of virus-
containing supernatant (diluted in DMEM without FCS) was added
to the cells and left for 2 h at 37°C. The infection mix was then aspi-
rated and DMEM containing 2% FCS and 0.8% SeaPlaque Agarose
(Lonza) was added and left for 10 min at room temperature to allow
the agarose to solidify. Cells were then cultured at 37°C in 10% CO2
for 2 days after which plaques were stained for 2 h at 37°C by adding
0.1 volume of MTT solution (5 mg ml1 in PBS; Sigma).
Assay to monitor the antiviral activity of dsRNAi
Cells were seeded and transfected with long dsRNA as described
above. One day after transfection, the medium was removed and
the required dose of SFV-Rluc (diluted in serum-free DMEM) was
added and left for 2 h at 37°C. The infection mix was then removed,
and complete medium (DMEM containing 10% FCS and antibiotics)
was added on the cells. Twenty-four hours post-infection, the
medium was recovered for analysis of viral concentration by plaque
assay and cells were lysed in 1× Passive Lysis buffer (Promega).
Luciferase activity was analysed in cell lysates using the Dual-
Luciferase Reporter Assay System (Promega) and measured on an
Envision 2102 Multilabel Reader (PerkinElmer).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6. A
P-value < 0.05 was considered statistically significant.
Expanded View for this article is available online.
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